Michael Urdea
Directeur/Membre du Conseil chez PRESSURE BIOSCIENCES, INC.
Fortune : 6 971 $ au 31/05/2024
Profil
Dr. Michael S.
Urdea is an Independent Director at Pressure BioSciences, Inc., a Founding Partner at Halteres Associates LLC and a Chairman at Catalysis Foundation For Health.
He is on the Board of Directors at Pressure BioSciences, Inc. and Quantum Dot Corp.
Dr. Urdea was previously employed as a Chief Executive Officer by Tethys Bioscience, Inc., a Chairman & Chief Executive Officer by Singulex, Inc., a Chief Scientific Officer & Head-Molecular by Bayer Diagnostics Corp., a Member-Diagnostic Forum by Bill & Melinda Gates Foundation Trust, a VP-Nucleic Acid Diagnostics & New Markers by Chiron Corp., a Founder by Nucleic Acid Diagnostics, Inc., and a Member by The University of California, San Francisco.
He also served on the board at Adamas Pharmaceuticals LLC.
He received his undergraduate degree from Northern Arizona University and a doctorate degree from Washington State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/05/2024 | 30 287 ( 0,12% ) | 6 966 $ | 31/05/2024 | |
| 29/05/2024 | 20 ( 0,27% ) | 5 $ | 31/05/2024 |
Postes actifs de Michael Urdea
| Sociétés | Poste | Début |
|---|---|---|
| PRESSURE BIOSCIENCES, INC. | Directeur/Membre du Conseil | 08/02/2013 |
Quantum Dot Corp.
 Quantum Dot Corp. SemiconductorsElectronic Technology Quantum Dot Corp. develops and markets novel solutions for biomolecular detection. Its products and services employ quantum dot particles, tiny semiconductor crystals that emit light brightly in a range of sharp colors. The company was founded by Bala Manian in 1998 and is located in Hayward, CA. | Directeur/Membre du Conseil | 29/06/2009 |
Halteres Associates LLC
 Halteres Associates LLC Medical/Nursing ServicesHealth Services Halteres Associates LLC is a consulting firm founded in 2002 and based in an undisclosed location. The American company provides strategic and tactical consulting services to organizations in the areas of diagnostics, health, medical devices, and life science research. The private company leverage a robust network of industry professionals across multiple disciplines to assist organizations with technology creation and applications, product and market development, opportunity and economic analyses, business modeling, and more. The company's clients include large multinational companies, nongovernmental organizations, and emerging industry innovators. Halteres Associates is passionate about improving healthcare and can help create impact and value by matching medical innovation to market needs. | Fondateur | 01/01/2002 |
| Catalysis Foundation For Health | Fondateur | - |
Anciens postes connus de Michael Urdea
| Sociétés | Poste | Fin |
|---|---|---|
Singulex, Inc.
 Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | Président | - |
| Bayer Diagnostics Corp. | Directeur Technique/Scientifique/R&D | 01/01/2000 |
Bill & Melinda Gates Foundation Trust
 Bill & Melinda Gates Foundation Trust Financial ConglomeratesFinance The Bill & Melinda Gates Foundation was formed in 1997 as the William H. Gates Foundation. In 1999, the foundation was renamed the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation Trust was created in January 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation, which focused on improving global health. The foundation participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The foundation also provides funds to promote greater equity in global health, education and public libraries. Through their partnerships in communities across the US, the Bill & Melinda Gates Foundation is committed to raising the high school graduation rate and helping all students, regardless of race or family income. The foundation is headquartered in Seattle, Washington. | Corporate Officer/Principal | - |
| Nucleic Acid Diagnostics, Inc. | Fondateur | - |
Tethys Bioscience, Inc.
 Tethys Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Tethys Bioscience was dedicated to the discovery, development and commercialization of novel biological markers biomarkers that provided a practical tool to address the growing global challenge of chronic metabolic diseases such as diabetes. By developing new tests that used protein and other blood borne biomarkers to identify people at high risk for devastating and preventable diseases, they can arm patients and physicians with knowledge they can use to help prevent disease progression. These biomarkers gave a snapshot of an individual's current risk, which may be modifiable. Their goal was to provide clinicians with an objective and convenient means to risk-stratify their patients and help them focus appropriate intervention strategies on those most likely to benefit. Their research strategies lead to sets of biomarkers that can be used to quantify the level of an individual's risk. The company had become a pioneer in the discovery, development and value creation of novel biological markers for the clinical diagnostics marketplace: The company had built expertise, created significant intellectual property, and was executing its business plan around three key areas: Biomarker Discovery, Clinical Validation and ValueCreation. It was focused upon introducing products that yield significant savings to the health care system and improve the quality of life for patients. | Directeur Général | - |
Formation de Michael Urdea
| Northern Arizona University | Undergraduate Degree |
| Washington State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PRESSURE BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Bill & Melinda Gates Foundation Trust
Bill & Melinda Gates Foundation Trust Financial ConglomeratesFinance The Bill & Melinda Gates Foundation was formed in 1997 as the William H. Gates Foundation. In 1999, the foundation was renamed the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation Trust was created in January 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation, which focused on improving global health. The foundation participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The foundation also provides funds to promote greater equity in global health, education and public libraries. Through their partnerships in communities across the US, the Bill & Melinda Gates Foundation is committed to raising the high school graduation rate and helping all students, regardless of race or family income. The foundation is headquartered in Seattle, Washington. | Finance |
Quantum Dot Corp.
Quantum Dot Corp. SemiconductorsElectronic Technology Quantum Dot Corp. develops and markets novel solutions for biomolecular detection. Its products and services employ quantum dot particles, tiny semiconductor crystals that emit light brightly in a range of sharp colors. The company was founded by Bala Manian in 1998 and is located in Hayward, CA. | Electronic Technology |
Singulex, Inc.
Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | Commercial Services |
Tethys Bioscience, Inc.
Tethys Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Tethys Bioscience was dedicated to the discovery, development and commercialization of novel biological markers biomarkers that provided a practical tool to address the growing global challenge of chronic metabolic diseases such as diabetes. By developing new tests that used protein and other blood borne biomarkers to identify people at high risk for devastating and preventable diseases, they can arm patients and physicians with knowledge they can use to help prevent disease progression. These biomarkers gave a snapshot of an individual's current risk, which may be modifiable. Their goal was to provide clinicians with an objective and convenient means to risk-stratify their patients and help them focus appropriate intervention strategies on those most likely to benefit. Their research strategies lead to sets of biomarkers that can be used to quantify the level of an individual's risk. The company had become a pioneer in the discovery, development and value creation of novel biological markers for the clinical diagnostics marketplace: The company had built expertise, created significant intellectual property, and was executing its business plan around three key areas: Biomarker Discovery, Clinical Validation and ValueCreation. It was focused upon introducing products that yield significant savings to the health care system and improve the quality of life for patients. | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
| Bayer Diagnostics Corp. | Health Technology |
Halteres Associates LLC
Halteres Associates LLC Medical/Nursing ServicesHealth Services Halteres Associates LLC is a consulting firm founded in 2002 and based in an undisclosed location. The American company provides strategic and tactical consulting services to organizations in the areas of diagnostics, health, medical devices, and life science research. The private company leverage a robust network of industry professionals across multiple disciplines to assist organizations with technology creation and applications, product and market development, opportunity and economic analyses, business modeling, and more. The company's clients include large multinational companies, nongovernmental organizations, and emerging industry innovators. Halteres Associates is passionate about improving healthcare and can help create impact and value by matching medical innovation to market needs. | Health Services |
| Nucleic Acid Diagnostics, Inc. | |
| Catalysis Foundation For Health |
